Jump to content

ProofPilot

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Saccar-Kapho et Ghau (talk | contribs) at 10:26, 21 June 2024 (Model). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ProofPilot
Company typeClinical trial platform
Industry
Headquarters
Key people
Chris Venezia
ProductsProofPilot
Websitewww.proofpilot.com

ProofPilot is an American Internet company with offices in New York City. Its namesake product is a digital protocol automation platform that aims to eliminate guesswork and protocol deviations[how?] in clinical settings. Chris Venezia joined as the Chief Executive Officer in 2022.[1]

History

ProofPilot grew out of the consulting firm Cyclogram in 2013. Matthew Amsden started Cyclogram in 2005.[2]

Early versions of the platform supported studies in the United States, Brazil and Peru.[1] ProofPilot participated in the BluePrint Health Incubator program in the winter of 2014.[3]

Amsden has talked about the challenges of creating a digital health startup and the cultural disconnect between buyers and venture-capital-backed startups. He says that adherence to the typical venture-backed startup "rulebook" almost killed ProofPilot.[4] The company relaunched the product in late 2017 after not taking on customers for over two years.[5]

Model

The ProofPilot platform is split in three parts. The first gives users the ability to design research studies. The design process (and resulting participant experience) is based on a concept called micro-interactions.[6] Non-experienced study designers can use study templates and fill in the blanks to create a study.[7] The second is the participant experience. Study designers launch the study, it goes through an automatic external regulatory review by Veritas IRB in Montreal, Quebec, Canada.[8] Then participants begin engaging in the study via mobile phones and desktop computers. ProofPilot has publicly stated it has deprioritized development of a native iOS and Android application because Progressive web apps provide a better user experience.[9] The system also provides reporting of findings.

Regulatory and ethics review

In September 2016, ProofPilot formed a partnership with Veritas IRB in Montreal, Quebec, Canada. Given that many of its customers are not academic institutions and don't have an in-house review process, all studies launched on ProofPilot will be reviewed by Veritas before going live.[10]

See also

References

  1. ^ a b "ProofPilot™, Chris Venezia Named CEO of ProofPilot" (Press release). Retrieved December 22, 2022.
  2. ^ "ProofPilot™, New Online Research Tool Developed By Cyclogram, Launches To Make Research More Accessible And Affordable" (Press release). Retrieved 2017-01-30.
  3. ^ Pennic, Fred (3 April 2014). "Blueprint Health Showcases Its Fifth Class of 7 Startups at Demo Day in NYC". HITConsultant. Retrieved 2017-02-05.
  4. ^ Amsden, Matthew (29 May 2016). "Playing by 'startup rules' almost killed my digital health startup". VentureBeat. Retrieved 2017-01-30.
  5. ^ Comstock, Joshua (2016-05-10). "ProofPilot relaunches software to enable anyone to run an RCT". MobiHealthNews. Retrieved 2017-01-30.
  6. ^ Amsden, Matthew (2016-11-17). "How ProofPilot Uses Micro-Interactions To Make Designing A Research Study Easy And Visual". Medium. Retrieved 2017-01-30.
  7. ^ "ProofPilot launches digital health study templates for clinical research". iMedicalApps. 2016-12-29. Retrieved 2017-01-30.
  8. ^ "ProofPilot launches platform to help researchers run scientific studies about digital health devices and wellness programs". Healthcare IT News. 2016-11-23. Retrieved 2017-01-30.
  9. ^ Amsden, Matthew (2016-12-05). "Why a Native Mobile App Isn't Central to Our Strategy and Shouldn't Be for Yours Either". Medium. Retrieved 2017-01-30.
  10. ^ McCarthy, Jack (2016-11-16). "ProofPilot launches platform to help researchers run scientific studies about digital health devices and wellness programs". Healthcare IT News. Retrieved 2017-02-05.